68 results
8-K
EX-99.1
RGEN
Repligen Corp.
19 Mar 24
Repligen Appoints Maggie A. Pax to Board of Directors
7:41am
Scientific, where, from 2016–2020, she served as Vice President, Strategy and Innovation for the clinical supply chain business. In this role, she … led strategic planning, developed customer-facing innovation programs, and drove the business case for the company’s multi-billion acquisition
8-K
EX-99.1
RGEN
Repligen Corp.
15 Jun 20
Repligen Appoints Carrie Eglinton Manner to Board of Directors
7:36am
and process improvement. Her history of delivering on business expansion and profitability will be valuable as we continue to execute on our innovation-based … and molecular diagnostics portfolio. Under her leadership, the advanced diagnostics portfolio has grown revenue and margin through innovation in specialty genetic
8-K
EX-99.1
RGEN
Repligen Corp.
12 Sep 23
Repligen Appoints Jason K. Garland As Chief Financial Officer
9:20am
on driving success for our company through innovation, including M&A, while delivering above-industry growth and strong financial performance.” He continued … to meeting my new colleagues and working to execute on transactions and strategies that can build on Repligen’s innovation edge in the bioprocessing
8-K
EX-99.1
RGEN
Repligen Corp.
26 Apr 19
Repligen Corporation Announces Agreement to Acquire Process Analytics Innovator
7:45am
proud of the progress and impact we have made in biopharma over the past decade. Our culture of technology innovation and customer centricity is what … . is a privately-held, Bridgewater, NJ based company known for innovation in spectroscopy. The company designs and manufactures assemblies, instrumentation
8-K
EX-99.1
RGEN
Repligen Corp.
27 Feb 20
Repligen Appoints Rohin Mhatre, Ph.D. to Board of Directors
7:43am
of Repligen. “The relevance of Rohin’s experience to Repligen is clear. His skillsets and his passion for innovation underscore his success in driving
8-K
EX-99.1
da52rb1aluqf5wnmsa
1 Jun 22
Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors
5:25pm
8-K
EX-99.1
5uv2ldbc c7u4o
2 Oct 23
Repligen Appoints Olivier Loeillot As President and Chief Commercial Officer
7:42am
8-K
EX-99.1
85s04g0b5 9h5a1bl89
16 Sep 21
Proposed acquisition strengthens Repligen’s Proteins business
7:53am
8-K
EX-99.2
69ifjxvq
16 Sep 21
Proposed acquisition strengthens Repligen’s Proteins business
7:53am
8-K
EX-99.1
1hoiz5gw5qm2rmoen
26 Sep 23
Repligen Announces Agreement to Acquire
7:44am
424B7
zagjiav
5 Nov 21
Prospectus with selling stockholder info
4:16pm